home / stock / ango / ango news


ANGO News and Press, AngioDynamics Inc. From 04/08/20

Stock Information

Company Name: AngioDynamics Inc.
Stock Symbol: ANGO
Market: NASDAQ
Website: angiodynamics.com

Menu

ANGO ANGO Quote ANGO Short ANGO News ANGO Articles ANGO Message Board
Get ANGO Alerts

News, Short Squeeze, Breakout and More Instantly...

ANGO - AngioDynamics (ANGO) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. AngioDynamics   (NASDAQ: ANGO) Q3 2020 Earnings Call Apr 07, 2020 , 8:00 a.m. ET Operator Continue reading

ANGO - AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call Transcript

AngioDynamics, Inc. (ANGO) Q3 2020 Results Earnings Conference Call April 7, 2020 8:00 AM ET Company Participants Jim Clemmer - President & CEO Steve Trowbridge - EVP & CFO Conference Call Participants Jayson Bedford - Raymond James Jason Mills - Canaccord Genuity...

ANGO - AngioDynamics, Inc. 2020 Q3 - Results - Earnings Call Presentation

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2020 Q3 earnings Read more ...

ANGO - AngioDynamics +4% premarket on Q3 beat; 2020 guidance withdrawn

AngioDynamics ( ANGO +6.2% ) Q3 results : More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...

ANGO - AngioDynamics EPS beats by $0.04, beats on revenue

AngioDynamics (NASDAQ: ANGO ): Q3 Non-GAAP EPS of $0.01 beats by $0.04 ; GAAP EPS of -$0.15 misses by $0.01 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ANGO - AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results

Fiscal 2020 Third Quarter Highlights Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15; adjusted earnings per share of $0.01 Launched PATHFINDER I...

ANGO - AngioDynamics Q3 2020 Earnings Preview

AngioDynamics (NASDAQ: ANGO ) is scheduled to announce Q3 earnings results on Tuesday, April 7th, before market open. The consensus EPS Estimate is -$0.03 (-115.8% Y/Y) and the consensus Revenue Estimate is $68.55M (-20.6% Y/Y). Over the last 2 years, ANGO has beaten EPS estimates 50...

ANGO - Ablation Equipment Market Expected to Witness a Sustainable Growth by 2029

New York City, NY:March 26, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Ablation Equipment Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and i...

ANGO - Stocks To Watch: 0% To The Rescue?

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

ANGO - AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020 before the market open on Tu...

Previous 10 Next 10